Subcutaneous Versus Intravenous Rehydration in Hospitalized Older Adults: A Meta-Analysis.

Autor: Barreto Annes LM; Professor Fernando Figueira Integral Medicine Institute (IMIP), Recife, Pernambuco, Brazil (Mss Barreto Annes and da Cunha Andrade; Drs de Albuquerque Pontes, Sena, Telles, and de Orange). Laryssa Maryssan Barreto Annes, MSc, RN, is a registered nurse with a master's degree in palliative care at the Professor Fernando Figueira Integral Medicine Institute (IMIP). Rebeca Gonelli Albanez da Cunha Andrade, MSc, is an anesthesiologist at IMIP. Isabelle Eunice de Albuquerque Pontes, PhD, PT, is a physiotherapist and researcher at IMIP. Gabrielle R. Sena, MD, MSc, practices palliative care at IMIP. Jurema Telles, MD, PhD, is the deputy coordinator of the professional master's degree program in palliative care associated with the residency program in health at IMIP. Flávia Augusta de Orange, PhD, is a professor in the postgraduate program at IMIP. She also works as an anesthesiologist at IMIP and the Teaching Hospital of the Federal University of Pernambuco, Brazil., Andrade RGADC, Pontes IEA, Sena GR, Telles J, de Orange FA
Jazyk: angličtina
Zdroj: Journal of infusion nursing : the official publication of the Infusion Nurses Society [J Infus Nurs] 2020 Sep/Oct; Vol. 43 (5), pp. 283-291.
DOI: 10.1097/NAN.0000000000000388
Abstrakt: Subcutaneous rehydration is an optional infusion route in hospitalized older adults. This meta-analysis sought to compare the effectiveness of subcutaneous versus intravenous (IV) fluid administration to reverse mild-to-moderate dehydration in hospitalized older adults. A literature search was performed. No restrictions were imposed regarding language. Three randomized clinical trials conducted with patients 60 years of age or older treated with subcutaneous or IV rehydration were included, with a total sample size of 197 patients. Controlled quasi-randomized and crossover trials were excluded. The primary end point was reversal of dehydration. Secondary end points were patient satisfaction and frequency of adverse events (eg, cellulitis, edema, phlebitis, erythema, hyponatremia, and pain). Both treatments were effective in rehydrating the patients within 48 hours, with no statistically significant difference between the groups. Subcutaneous fluid administration effectively reversed dehydration while protecting against phlebitis. Since the quality of evidence was considerably low, further multicenter randomized clinical trials of efficient methodological quality should be conducted to consolidate the body of evidence.
Databáze: MEDLINE